Microbot Medical (MBOT) Retained Earnings (2010 - 2026)

Microbot Medical has reported Retained Earnings for 17 years, with the latest figure at -$107.8 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 15.19% year-over-year to -$107.8 million; the trailing twelve-month figure through Mar 2026 stood at -$107.8 million (down 15.19% YoY), and the FY2025 full-year result was -$104.1 million, down 14.45% from the prior year.
• Retained Earnings for Q1 2026 stood at -$107.8 million, down from -$104.1 million in the prior quarter.
• The five-year high for Retained Earnings was -$58.8 million in Q1 2022, with the low at -$107.8 million in Q1 2026.
• Historically, Retained Earnings has averaged -$82.6 million across 5 years, with a median of -$81.9 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings declined 27.12% — and 2024, when it retreated 14.12%.
• Microbot Medical's Retained Earnings stood at -$68.8 million in 2022, then fell by 15.62% to -$79.5 million in 2023, then fell by 14.39% to -$90.9 million in 2024, then retreated by 14.45% to -$104.1 million in 2025, then fell by 3.53% to -$107.8 million in 2026.
• The last three Retained Earnings figures came in at -$107.8 million (Q1 2026), -$104.1 million (Q4 2025), and -$100.6 million (Q3 2025), per Business Quant data.